Although thymus-matured T cells are not necessary for in vivo B cell responses to a class of antigens designated T-independent (TI) 1 (1, 2), we wished to determine whether T cells could influence the nature of the antibody produced. It was our hypothesis that in a TI antigen system in which there is no obligate need for carrierspecific helper T cell triggering signals, T cells may still exert subtle regulatory effects on the B cell antibody response via a distinct population of Ig-specific regulatory cells (3-9). If this were indeed the case, such a system might be ideal for studying the regulatory effects of Ig-speeific T cells independently of carrier-specific T cells. The characteristics of Ig-specific T cell interactions with B cells could thus be elucidated and compared with the known characteristics of carrier-specific T cell-B cell interactions.
immunization. Pools of serum consisted of equal aliquots taken from the individual serum samples within a group. Experimental groups consisted of 3-10 mice.
Selective Enrichment for B or T Cell Populations.
To enrich selectively for B cells, nu/ + and nu[nu spleen cell populations were processed in the following manner. Red blood cells and dead cells were removed by sequential treatment with lysing buffer (12) and low ionic strength buffer (13) . Ceils were then treated with a 10 -~ dilution ofa monoclonal anti-Thy-l.2 antibody (New England Nuclear Corp., Boston, Mass.) at a cell concentration of 5 × 10S]ml for 45 rain at room temperature, centrifuged, and further incubated with a 1:15 dilution of guinea pig complement (C) (Flow Laboratories, Inc., Rockville, Md.) for 45 min at 37°C. The anti-Thy-1.2 and C treatment was repeated. Dead cells were removed by reexposure to low ionic strength buffer. In a typical experiment, treated cells from nu/nu mice were 78% Ig +, whereas those from nu/+ mice were 82% Ig + by fluorescence microscopy.
Spleen cell suspensions were selectively enriched for T cells by the method described by Mage et al. (14) . After two goat anti-Ig-coated plate passages, the resulting nonadherent cells ranged from 1-3% Ig + and 83-95% Thy-I +. Cell recovery in nonadherent fraction ranged from 2O-30%.
Radioimmunoassayfor Anti-TNP Antibody. Flexible polyvinyl chloride microtiter plates (Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, Vs.) were coated with 10 #g/ml TNP bovine serum albumin (BSA) in phosphate-buffered saline (PBS), pH 7.4 (50 #l/well). TNP-BSA was prepared according to the method of Rittenberg and Amkraut (15) and contained 20 mol of TNP/mol of BSA. After 1 h, plates were washed and coated with 50% fetal calf serum (North American Biologicals, Inc., Miami, Fla.) to prevent further nonspecific binding (100 #1/ well). After a further 1 h incubation, the plates were washed four times and 50 #1 of the appropriate serum diluted in assay buffer (PBS containing 1% BSA + 0.1% sodium azide + 0.005 M disodium ethylenediamine tetraacetate) was added. Anti-TNP serum dilutions were incubated in the wells for 3 h after which the wells were washed six times with PBS, and 50 #1 of the appropriate 3H-labeled antibody (described below) was added in assay buffer to each well. After an additional 3-h incubation, the labeled antibody was removed, the plates were washed 13 times with tap water, and the wells were subsequently separated by slicing off the top of the microtiter plate. Each well was placed in scintillation fluid and measurements of the amount of bound all-labeled antibody were made in a liquid scintillation spectrometer.
Anti-TNP sera were tested at 8 or 12 twofold dilutions. When log counts per minute bound was plotted against the log of serum dilution, a curve with a linear region was obtained. This linear region generally included the point at which 1% of added 3H anti-Ig was bound. The serum dilution that bound 1% was obtained from the curve and this value was reported as the antibody titer.
Myeloma Proteins used to Purify and Test Specificity of Anti-lsotype Antibodies. Myeioma proteins
were purified from ascitic fluids of mice bearing MOPC-21, MOPC-245, UPC-10, CBPC-101, MOPC-195S, and BPC-4 plasmacytomas [respective class and allotype designations (16) are IgGl, Igh-4a; IgG1, Igh-4b; IgG2a, Igh-la; IgG2a, Igh-lb; IgG2b, Igh-3a; and IgG2b, Igh-3b] by a protein-A Sepharose pH gradient elution technique (17) . TEPC-183, MOPC-104E, TEPC-15, FLOPC-21, and J606 purified Igh a myeloma proteins (IgM, IgM, IgA, IgG3, and IgG3, respectively) were commercially obtained (Litton Bionetics, Kensington, Md.). Purified myeloma proteins representative of the various isotypes were coupled to cyanogen-bromide-activated Sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piseataway, N. J.) and used as immunoadsorbents.
Preparation of Isotype-Specific Antibodies. Sera from goats (G) immunized with Fc fragments from MOPC-31C (Igh-4a), RPC-24B (Igh-la), CBPC-101 (Igh-lb), or MPC-37 (Igh-3a) in complete Freund's adjuvant (CFA) and from rabbits immunized with FLOPC-21 (IgG3) in CFA were rendered subclass-specific by adsorption on Sepharose columns coupled with myelomas of other isotypes. They were affinity purified using columns containing myeloma proteins of the isotype used for immunization. Affinity-purified G anti-IgM was a gift of Dr. Donna Sieckmann (Naval Medical Research Institute, Bethesda, Md.). Affinity-purified antibodies at a concentration of 0.5-1.5 mg/ml were tritiated with NaBSH4 (sp act 40-50 C/mM; New England Nuclear) by the reductive methylation procedure of Wilder et al. (18) . all-labeled antibodies had specific activities ranging from 0.5-2.6 × 106 cpm/#g. They were diluted in PBS + 2% BSA + 0.1% sodium azide, and stored in liquid nitrogen for up to 1 yr without noticeable loss of activity.
Analysis of Specificity of 3H-labeled Anti-Isotype Reagents. Tests for specificity were done by measuring the direct binding of all-labeled reagents to microtiter wells precoated with purified myeloma proteins representative of the various isotypes. In the ease of the IgG1, IgG2a, and IgG2b subclasses, binding to myeloma proteins of both the Igh a and Igh h allotypic forms was measured. In addition, inhibition assays were performed to compare the ability of various isotypic forms of the myeioma proteins to inhibit the binding of all-labeled antibodies to platebound myeloma proteins. Through the combination of these approaches, the 3H-labeled antiisotype reagents were ascertained to have specificity for the isotype used for immunization. The G anti-CBPC-101 reagent had specificity for the Igh-1 b allotypic form of IgG2a.
Comparison of the Binding Efficiencies of the Various 3H-labeled Anti-Isotype Antibodies. To validate the comparison of anti-TNP-antibody titers of one isotype versus another, the binding efficienties of the various labeled antibodies were compared in terms of counts per minute bound to a known quantity of a given isotype. Wells were coated with affinity-purified rabbit anti-kappa light chain antibody. After washing, saturating nonspeeific binding sites with 1% BSA in assay buffer, and washing again, all-labeled myeloma proteins were added to the wells, the percent counts per minute bound was determined, and the absolute amount of myeloma (in nanograms) bound to the rabbit anti-kappa coated wells was then calculated. The amount of tritiated myeloma protein chosen for addition in these experiments was determined by prior studies to be in the linear portion of a dose-response curve relating amount of myeloma protein added and amount of tritiated anti-Ig antibody bound. Specific activities of TEPC-183, MOPC-21, GBPG-101, MOPG-195S, and FLOPC-21 labeled proteins were 2.0 X 106, 1.7 X 106, 2.0 × 106, 1.9 X 106, and 2.5 X 106 cpm//~g, respectively. To some of the wells that had bound aH myeloma'protein, all-labeled anti-isotype antibody (40,000-70,000 cpm) was added. The percent all-labeled anti-isotype antibody bound per nanogram of myeloma bound was calculated as shown in Table I .
As seen in the final column, the binding efficiencies, expressed as percent anti-isotype counts per minute bound per nanogram of bound myeloma varied between 4.6 and 9.4. The fact that these binding efficiencies did not vary by more than a factor of two enabled us to compare binding titers from one subclass to another.
Results

Isotypic Distribution of Anti-TNP Antibody in nu/nu and nu/ + Mice after Injection with
TNpoFicoll or TNP-Levan. To determine whether the presence of a thymus and hence mature T lymphocytes had any influence on the relative amounts of antibody of the IgM, IgG1, IgG2a, IgG2b, and IgG3 isotypes produced after immunization of mice with a TI antigen, congenitally athymic C57BL10/ScN nu/nu and thymus-bearing nu/+ age-and sex-matched mice were injected with 10 #g TNP-Ficoll or 10 #g TNPLevan intraperitoneally. Sera from mice taken on days 5,and 10 after immunization were tested for their titers of anti-TNP antibody of the various Ig isotypes. The data in Table II show that both nu/nu and nu/+ mice gave vigorous responses to the two TI antigens. In both sets of mice, the IgM titer was highest at day 5, whereas the IgG titers were highest at day 10. Although the IgM, IgG3, and IgG1 responses in both nu/nu and nu/+ mice were comparable, the IgG2a response was substantially higher (30-to 100-fold) in thymus-bearing nu/+ mice than in nu/nu mice. The IgG2b response was also somewhat higher in nu/+ mice but this difference was not as pronounced as in the IgG2a response. The results suggest that the congenital absence of a thymus can selectively impair the IgG2a and IgG2b responses to TI-2 antigens. twofold. As expected, unreconstituted (CBA/N × C57BL/6)F] male mice with a defect determined by the X chromosomal gene, xid (19) , failed to respond to TNPFicoll. In fact, the background anti-TNP-titer in these mice dropped as successive bleeds were taken.
Comparison of lsotypes of Anti-TNP Antibody Produced by Purified nu/nu and nu/ + B Cells
Thus, the data from this experiment showed that when nu/nu and nu/+ B cells are transferred into an identical milieu containing T cells, the amounts of the various isotypes of antibody they produce to this TI antigen are comparable. nu/+ and T cell reconstituted nu/nu mice showed a dramatic elevation in IgG2a anti-TNP titers when compared with nu/nu mice over the entire course of the response.
Effect of T Cell Reconstitution of nu/nu
The elevation of IgG2b titers in T cell-bearing mice was substantial but not as pronounced. In contrast, no major effect of T cells on the peak titers of IgM, IgG3, and IgG1 antibody was seen. In both nu/nu and T cell-bearing mice, the peak IgM response was found to precede the peak IgG response by several days. In T cellbearing mice, the peak response of the IgG1, IgG2a, IgG2b, and IgG3 isotypes was seen somewhat earlier than in nu/nu mice. In addition, a finding in this and other experiments was that anti-TNP serum titers in T cell-bearing mice generally tended to decline more rapidly than in nu/nu mice.
In summary, the two experiments above suggest that the relatively lower IgG2a response made by nu/nu mice to the TI antigen TNP-Ficoll is the result of the absence of T lymphocytes during the B cell response rather than the result of a maturational arrest of nu/nu B cells or a suppressive influence present in nu/nu mice.
To determine the minimal number of T lymphocytes that can affect the nu/nu IgG2a response to TNP-Ficoll, graded numbers of T lymphocyte-enriched spleen cells were injected into nu/nu mice, and the IgG1 and IgG2a titers were compared on day 16 after TNP-Ficoll immunization. The data in Fig. 3 show that as few as 1.25 × 10 + T lymphocytes can cause a significant boost in the IgG2a response of nu/nu recipients to TNP-Ficoll. Increasing the number of transferred T cells did not appear to further increase the response. Although 2.5 × 106-107 T cells somewhat elevated the IgG1 response in nu/nu mice, this increase was less than threefold.
In Table III In most experiments C57BL/KaLwN T cells were transferred into C57BL10/ScN nu/nu mice. Because C57BL/KaLwN and C57BL/10 sublines have some minor differences, the possibility existed that this selective enhancement of IgG2 antibody was the result of a minor allogeneic effect. That this is not the case is demonstrated in experiment 2 in which the transfer of C57BL10/ScN T cells has the same effect.
A trend that becomes obvious when comparing the titers of the various isotypes in the nu/nu reponse to TNP-Ficoll is that the strength of the response of the gamma isotypes is in the following order: IgG3 > IgG 1 > IgG2b > IgG2a. The presence of T cells, however, shifts this isotypic distribution so that higher levels of IgG2b and IgG2a are produced and this hierarchy in response becomes less pronounced. The validity of comparing the radioimmunoassay titers of the diverse isotypes has been discussed in Materials and Methods.
Discussion
It is now clear that certain antigens, designated TI antigens, can stimulate B cells to proliferate and to differentiate into antibody-producing cells in the absence of detectable ancillary T cell signals (1, 2) . This study has shown that B cells in athymic nude mice can be triggered by TNP-Ficoll and TNP-Levan to secrete not only IgM but also IgG 1, IgG2a, IgG2b, and IgG3 antibody. Thus B cells can, in an environment containing few, if any, thymus-matured T lymphocytes, produce antibody of many isotypes. Interestingly, the relative amount of anti-TNP antibody of the various isotypic classes produced by nude mice immunized with TNP-Ficoll was found to correlate directly with the 5' to 3' heavy chain constant region gene order in the mouse (20) . Thus, in a series of experiments, we found that the peak titers of anti-TNP antibodies were in the following order: IgM > IgG3 > IgG1 > IgG2b > IgG2a. It is unlikely that differential catabolism of the various Ig isotypes is responsible for this heirarchy in serum titers. Comparisons of the known catabolic rates of IgM, IgG1, IgG2b, and IgG2a (140, 17, 25, and 13% per day, respectively) (21) with the maximal anti-TNP titers of each isotype measured fail to show any correlations. This observation raises the provocative possibility that the frequency of responding cells of a given isotype is dependent on the distance of the particular constant region gene from the site(s) 5' to the # gene reported to be involved in gene switching (22) .2 Whether B cell responses to TI-2 antigens other than TNP-Ficoll and TNP-Levan will also reflect this gene order, and whether it is a feature of all inbred strains, is currently under investigation.
Our predominant interest has been to determine whether these levels of antibody of the various isotypes might be influenced by T lymphocytes and, if such T cell regulation exists, what mechanisms might be involved. Our data indicate that unprimed T lymphocytes can in fact influence the distribution of isotypes produced to TI antigens of the TI-2 class. A positive T cell influence was seen predominantly on IgG2a, an isotype that was poorly produced in athymic nu/nu mice. A slight effect of T cells on IgG2b antibody production was also observed. This selective regulatory effect of T cells on IgG2a and IgG2b antibody production did not increase the levels of these isotypes beyond the levels of IgM, IgG3, and IgG 1. This is in agreement with the observation of Slack et al. (23) that the IgG3 and IgG1 plaque-forming cell responses of normal thymus-bearing mice to TNP-Ficoll are significantly greater than the combined IgG2a and IgG2b plaque-forming cell responses.
We have considered two major explanations for the preferential helper T cell effect on IgG2 production. (24) . Although the effective T cell populations used here have not been primed, we cannot exclude the possibility that they have such specificity for TNP. Finally, the ancillary T cells may have specificity for a membrane-bound B cell determinant, perhaps Lyb3, Lyb5, Lyb7, or Ia (25-27).
We are not yet able to distinguish between these two major mechanisms by which T cells may enhance IgG2a production by B cells. It is clearly of interest to determine the specificity of the effector T cell population and to determine whether it interacts with B cells to result in an increased number of IgG2a-positive clones or simply increased IgG2a production from already differentiated clones.
When investigating the response kinetics of the various isotypes in T cell-bearing and athymic mice, several observations were made with regard to the rapidity and the prolongation of the response. First, in mice bearing T cells, the peak IgG1, IgG3, IgG2b, as well as IgG2a, antibody titers were generally seen earlier than in nude mice. This suggests that T cells may subtly influence the rate of differentiation to IgG production. It should be noted again that, in terms of magnitude of the overall response, only the IgG2a and IgG2b isotypes were affected by T cells. Because IgM production was not assayed prior to day 5 after immunization, a time of peak serum IgM levels, we cannot determine whether T cells accelerated the IgM response. It has recently been shown that the in vitro IgM anti-TNP response of mouse spleen cells to TNP-Ficoll can be markedly diminished by vigorous depletion ofT lymphocytes (28) . It is conceivable that this effect is related to the capacity oft cells to accelerate B cell antibody production.
In addition to hastening the production of IgG after TNP-Ficoll immunization, the presence of T cells also caused a more pronounced fall in antibody titer after peak production had been achieved. Recent studies (29) have suggested that this might be the result of T cell-dependent anti-idiotype-induced regulation of the TNP-Ficoll response.
In numerous experiments in which the kinetics of the response of the various isotypes was investigated, peak titers of each isotype were generally seen at the same time. This suggests that in the differentiation of a TNP-Ficoll responsive B cell, sequential switching of a given B cell through IgM ~ IgG3 ~ IgG1 ~ IgG2b --0 IgG2a stages is unlikely. Instead it suggests that, if an antigen-induced switching event does take place, a more likely used differentiation pathway is one in which progeny of a given B cell clone each diverge and switch from an IgM-positive stage to an IgG3, IgG1, IgG2b, or IgG2a-positive stage at approximately the same time.
These experiments have suggested that the Ig constant region gene order may inherently control the amount of antibody of the various isotypes produced when B lymphocytes are stimulated by TI-2 antigens. Furthermore, our results suggest that the isotypic distribution is influenced by additional signals given by T lymphocytes. It is possible that, in B cell responses to every type of antigen, the deviation from a heirarchic isotypic response reflecting gene order is dependent on the nature of additional signals that a responding virgin B cell received, i.e., strong or weak T cell signals or strong or weak polyclonal activating signals inherent to the antigen. The delivery of strong signals to B lymphocytes may cause an increase in heavy chain gene switching. Finally, helper T cells that recognize specific isotypic determinants on B cell progeny that have switched their membrane isotype could even further expand the production of certain isotypes over that of others. The combined effects of these various antigenic and cellular signals would then create the isotypic distribution characteristic of a B cell response to a given antigen.
Summary
The effect of T lymphocytes on the IgM, IgG3, IgG I, IgG2b, and IgG2a responses of B lymphocytes to the type-2 T-independent antigens, trinitrophenylated (TNP)-Ficoll, and TNP-Levan, was investigated. T cell-bearing nu/+ mice were found to produce substantially higher IgG2 serum anti-TNP antibody than their athymic counterparts, with nu/nu and nu/+ IgG2a titers exhibiting more disparity than nu/nu and nu/+ IgG2b titers. The IgM, IgG3, and IgG1 anti-TNP levels in nu/nu and nu/+ mice were indistinguishable. By cell transfer experiments, it was determined that this variance in nude and heterozygote IgG2 responses could not be explained by B cell differences between the two strains or by suppressive effects on IgG2 production within nu/nu mice. Rather, the difference was shown to be the result of the absence of T cells at the time B cells were responding to antigen. In the absence of T cells, the strength of the nu/nu anti-TNP antibody response was found to be in the following order: IgM > IgG3 > IgG1 > IgG2b > IgG2a, a heirarchy identical with the recently proposed heavy chain gene order. The possibilities that T cells influence IgG2 production via their specific recognition of IgG2-bearing B cells or via signals to increase heavy chain switching of responding B cell clones are discussed.
